Increasing prevalence of ophthalmic diseases is supporting the growth of Global Artificial Cornea and Corneal Implants Market.
According to TechSci Research report, “Global Artificial Cornea and Corneal Implants Market By Type (Human Cornea v/s Artificial Cornea) By Transplant Type (Penetrating Keratoplasty v/s Endothelial Keratoplasty) By Disease Indication (Fuchs’ Dystrophy, Keratoconus, Fungal Keratitis, Others) By End User (Hospitals, Ambulatory Care Centers, Others) By Region, Competition Forecast & Opportunities, 2026”, the global artificial cornea and corneal implants market is anticipated to show robust growth in the upcoming five years owing to the major factors like rising population of the old people. Older population have a tendency of contracting various high-risk eye diseases, also vision impairment and corneal rupture is quite frequent in the geriatric population, supporting the growth of global artificial cornea and corneal implants market in the next five years.
Moreover, organizations like Eye Bank Association of America (EBAA) and The Global Alliance of Eye Bank Associations are creating a lot of awareness and are promoting policies regarding effective corneal transplantation and encouraging the patients to choose the procedure. This factor is actively supporting the global artificial cornea and corneal implants market growth in the next five years. Additionally, the market experiences a surge in demand of non-invasive or minimally invasive procedure for various medical diagnostic and surgical requirements thereby boosting the growth of global artificial cornea and corneal implants market from 2022 to 2026.
Browse over XX market data Figures spread through 110 Pages and an in-depth TOC on “Global Artificial Cornea and Corneal Implants Market”
The global artificial cornea and corneal implants market is segmented by type, transplantation type, disease indication, end user, competitional landscape and regional distribution. Based on transplantation type the market is further segmented into penetrating keratoplasty v/s endothelial keratoplasty. Penetrating keratoplasty is the dominant market segment with the largest shares in the historical period. Penetrating keratoplasty is also anticipated to assert its dominance over the market in the upcoming five years, owing its growth to the safety and efficiency of the procedure. Although the market segment faces a minor threat from its alternate procedure; endothelial keratoplasty.
Endothelial keratoplasty is anticipated to record fastest growth in the upcoming market owing its growth to the promising results the procedure shows. The endothelial keratoplasty is the latest approach in the market and involves minimal invasion like it only replaces the affected tissue rather than the complete cornea. Availability of the human cornea for the replacement is an issue that becomes null and void because of the efficiency of the endothelial keratoplasty procedure. Moreover, the procedure helps with the faster and better visual restoration with decreased risk of eye infection and any pother accidental mishaps during procedure. Also, growing prevalence of Fuchs dystrophy is anticipated to support the robust growth of the market segment.
Based on disease indication, the market is further bifurcated into Fuchs’ dystrophy, keratoconus, fungal keratitis, and others. Rising geriatric population is quite susceptible to contracting Fuchs’ dystrophy. The disease held the largest as well as the fastest growing market share. It is anticipated to assert its dominance in the forecast period too. Keratoconus disease held the significant share of market too, rising number of the patient suffering from keratoconus often reach the stage where they require corneal implant to regain their normal vision. Advanced procedures like Deep Anterior Lamellar Keratoplasty (DALK) bestows the advantage, the factor, along with FDA approved corneal implants are major drivers of the market growth in the forecast period.
Top players of the market are F. Hoffmann-La Roche Ltd, Regeneron Pharmaceuticals, Inc, Alcon, Inc., Bayer AG, Bausch & Lomb Incorporated, AJL Ophthalmic S.A., CorneaGen Inc., Addition Technology, Inc., LinkoCare Life Sciences AB, Presbia plc, Mediphacos, Aurolab (Aravind Eye Care System), LinCor Biosciences, Pte. Ltd. (Cornea Biosciences), DIOPTEX GmbH, EyeYon Medical Ltd.., among others. Other strategies include partnerships among the players and technologically advanced product launches.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=7608
Customers can also request for 10% free customization on this report.
“Major players of the market are headquartered in the North American region. The efficient reimbursement policies by the government of large economies like United States in the region, make North America the dominating sector for the market. Moreover, the players are actively involved in the research and development of the implants and efficient processes thereby supporting the market growth in the forecast period. Asia Pacific region is expected to be fastest growing market. New markets in the developing countries are emerging and the cost-effective procedures in these countries would help strengthen the market in countries like China, Indonesia, Philippines,” said Mr. Karan Chechi, Research Director with TechSci Research, a research based Global management consulting firm.
“Global Artificial Cornea and Corneal Implants Market By Type (Human Cornea v/s Artificial Cornea) By Transplant Type (Penetrating Keratoplasty v/s Endothelial Keratoplasty) By Disease Indication (Fuchs’ Dystrophy, Keratoconus, Fungal Keratitis, Others) By End User (Hospitals, Ambulatory Care Centers, Others) By Region, Competition Forecast & Opportunities, 2026”, has evaluated the future growth potential of global artificial cornea and corneal implants and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in global artificial cornea and corneal implants.
Mr. Ken Mathews
708 Third Avenue,
New York – 10017